 |
|


|
Relief for Xerostomia Sufferers |
Numoisyn™ Lozenges—Numoisyn™
Lozenges dissolve slowly while moved around in the mouth. They
contain sorbitol and malic acid to stimulate
normal salivation and provide temporary relief of dry mouth
in patients who have some residual secretory function and
taste perception. Numoisyn™
Lozenges support saliva’s natural protection of teeth so
that teeth are not damaged with repeated use of the lozenges(*1).
They are sugar free and buffered with calcium to protect teeth.
Numoisyn™ Lozenges
have been demonstrated to be safe and effective for long-term
use and are well tolerated by patients(*1). Use of Numoisyn™ Lozenges
improves subjective symptoms of dry mouth(*2) and does not cause
bacteria or plaque formation or loss of tooth enamel hardness(*3).
Pharmacological agents, usually cholinergic agonists, trigger
secretory function. Alternatively, saliva secretion may be increased
with bitter-tasting substances or mechanical stimulation, such
as chewing sugar-free gum or sucking sugar-free sweets. Numoisyn™
Lozenges increase salivary secretion by stimulating gustatory
(taste) pathways. Additionally, Numoisyn™ Lozenges can
be used as a diagnostic tool to evaluate salivary function.
Numoisyn™ Liquid—Numoisyn™
Liquid is an oral solution used to replace natural saliva when
salivary glands are damaged. The viscosity of Numoisyn™
Liquid is similar to that of natural saliva. Linseed extract
in Numoisyn™ Liquid contains mucins that provide superior
viscosity and reduced friction compared to water or carboxymethylcellulose
(CMC) solutions(*4). In fact, linseed extract significantly
reduces the symptoms of dry mouth, an effect that increases over
time while Numoisyn™ Liquid is used(*4).
Patients with xerostomia typically
have a high number of acid-tolerant microorganisms (eg, lactobacilli,
mutans streptococci, yeast) that contribute to plaque and gingival
bleeding. Numoisyn™ Liquid reduces the presence of plaque
and gingival bleeding to a greater extent than CMC(*4), and
it can be used in conjunction with chlorhexidine without impairing
the antibacterial effects of chlorhexidine(*5).
From a practical viewpoint, the duration of the effect of Numoisyn™
Liquid is approximately twice that of CMC(*4), and patients require
about three times as much volume of CMC compared to the volume
required for a similar dose of Numoisyn™ Liquid. Numoisyn™ Liquid is
well-tolerated by patients and most patients experience and
improvement in chewing, swallowing and burning sensation (*6).
Although patients frequently sip water to relieve the symptom
of dry mouth, water does not have the protective effects associated
with the many other components of saliva. Saliva substitute
preparations provide longer-lasting relief than water because
they increase viscosity and lubrication of oral fluid. In addition,
Numoisyn Liquid™ forms a film on hard and soft surfaces to protect
teeth and gums (*7).

Please refer to the or for specific product and prescribing
information.
If you are a Healthcare Professional and would like to
contact us regarding our products, please .
References:
1. Axelsson P, Larsson, U-B. The saliva stimulating
tablet SST in long-term clinical trial. Tandlakartidningen. 1991;83:698-
699. 2. Data on file, Align Pharmaceuticals. 3. Data on file, Align Pharmaceuticals. 4. Andersson
G, Johansson G, Attstrom R, Edwardsson S, Glantz P-O, Larsson
K. Comparison of the effect of the linseed extract Salinum ® and
a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology. 1995;12:12-17. 5. Johansson
G, Andersson G, Edwardsson S, et al. Effects of mouthrinses
with linseed extract Salinum without/with chlorhexidine on
oral conditions in patients with Sjögren’s syndrome:
A double-blind crossover investigation Gerodontology. 2001;18(2):87-94 6. Johansson
G, Andersson G, Attstrom R, Glantz P-O, Larsson K. The effect
of Salinum on the symptoms of dry mouth: a pilot study. Gerodontology. 1994;11:46-49. 7. Christersson
CE, Lindh L, Arnebrant T. Film-forming properties and viscosities
of saliva substitutes and human whole saliva. Eur J Oral
Sci. 2000;108:418-425.
|
 |
 |
|
 |